EUVIMEDEUVIMED entdecken
Fallbericht

Long-Term Subcutaneous Foslevodopa/Foscarbidopa Infusion Restores Oral Intake and Ambulation in Advanced Parkinson’s Disease After Deep Brain Stimulation: A Case Report

Atsushi Mizuma, Shizuka Netsu, Chiemi Nishikawa, Takato Abe, Eiichiro Nagata

Cureus · 05.11.2026

DOI: 10.7759/cureus.119192 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cureus, erschienen am 05.11.2026. Verfasst von Atsushi Mizuma und 4 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Mizuma, A., Netsu, S., Nishikawa, C., Abe, T., & Nagata, E. (2026). Long-Term Subcutaneous Foslevodopa/Foscarbidopa Infusion Restores Oral Intake and Ambulation in Advanced Parkinson’s Disease After Deep Brain Stimulation: A Case Report. Cureus. https://doi.org/10.7759/cureus.119192

Vancouver

Mizuma A, Netsu S, Nishikawa C, Abe T, Nagata E. Long-Term Subcutaneous Foslevodopa/Foscarbidopa Infusion Restores Oral Intake and Ambulation in Advanced Parkinson’s Disease After Deep Brain Stimulation: A Case Report. Cureus. 2026. doi:10.7759/cureus.119192

BibTeX
@article{Mizuma2026,
  author = {Mizuma, Atsushi and Netsu, Shizuka and Nishikawa, Chiemi and Abe, Takato and Nagata, Eiichiro},
  title = {Long-Term Subcutaneous Foslevodopa/Foscarbidopa Infusion Restores Oral Intake and Ambulation in Advanced Parkinson’s Disease After Deep Brain Stimulation: A Case Report},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.119192}
}
Kostenlos starten →